Fig. 1From: Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysisLocoregional control of 58 advanced larynx-hypopharynx cancer patients by use of antiplatelet drugsBack to article page